Frequently Asked Questions (FAQs)
-
What types of conditions do you treat?
I treat all psychiatric conditions, including depression and anxiety. I specialize in treating substance use disorders, ADHD, and trauma. My approach integrates medications, and psychodynamic psychotherapy with evidence-based techniques such as CBT, DBT, ACT, and Motivational Interviewing.
-
Do you accept insurance?
I accept Aetna, Cigna, Optum (including UnitedHealthcare, UMR, and Oscar), Carelon Behavioral Health, and Anthem Blue Cross Blue Shield insurance plans through Alma in Colorado. For out-of-network care, I operate on a fee-for-service basis, with payment due at the time of service. If you have out-of-network benefits, I can provide a superbill for you to submit to your insurance company for potential reimbursement, depending on your plan.
-
What are your fees?
Initial Psychiatric Evaluation: $475
50-Minute Psychotherapy with Medication Management: $285
50-Minute Psychotherapy Only: $250
15-Minute Medication Management Only: $200
-
What is psychodynamic psychotherapy?
Psychodynamic psychotherapy is a type of therapy that looks at the hidden patterns and emotions that affect how you think, feel, and act. It helps you understand these deeper issues, often linked to early life experiences, to improve self-awareness and support long-term emotional growth and healing.
-
What can I expect during the initial evaluation?
The initial consultation lasts 60 to 90 minutes and involves a thorough review of your psychiatric, medical, and social history. We will discuss your current challenges, explore treatment goals, and determine whether that involves psychotherapy, medication, or a combination of both.
-
Do you offer telehealth services?
Yes, I currently offer telehealth services for all appointments. I also offer in-person sessions for those who prefer face-to-face meetings.
-
Do you offer newer treatments for cravings or compulsive behaviors?
In some cases, yes. For individuals who continue to struggle with cravings despite standard approaches, we may discuss a broader range of options as part of a personalized treatment plan.
This can include medications that affect appetite, reward, and impulse regulation systems. Among these are GLP-1 receptor agonists (such as semaglutide), which are FDA-approved for metabolic conditions but are being studied for their potential effects on cravings and compulsive behaviors.
These uses are considered off-label, and not everyone is a candidate. Any decision to use these medications is made carefully, with attention to your medical history, current symptoms, and overall treatment goals. When appropriate, they are integrated into a broader plan that may include psychotherapy and other medications.